Cargando…

Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact

Detalles Bibliográficos
Autores principales: Yip, Terry Cheuk-Fung, Wong, Grace Lai-Hung, Wong, Vincent Wai-Sun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046624/
https://www.ncbi.nlm.nih.gov/pubmed/33517606
http://dx.doi.org/10.3350/cmh.2021.0019
_version_ 1783678887720386560
author Yip, Terry Cheuk-Fung
Wong, Grace Lai-Hung
Wong, Vincent Wai-Sun
author_facet Yip, Terry Cheuk-Fung
Wong, Grace Lai-Hung
Wong, Vincent Wai-Sun
author_sort Yip, Terry Cheuk-Fung
collection PubMed
description
format Online
Article
Text
id pubmed-8046624
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Korean Association for the Study of the Liver
record_format MEDLINE/PubMed
spelling pubmed-80466242021-04-22 Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact Yip, Terry Cheuk-Fung Wong, Grace Lai-Hung Wong, Vincent Wai-Sun Clin Mol Hepatol Editorial The Korean Association for the Study of the Liver 2021-04 2021-02-01 /pmc/articles/PMC8046624/ /pubmed/33517606 http://dx.doi.org/10.3350/cmh.2021.0019 Text en Copyright © 2021 by The Korean Association for the Study of the Liver https://creativecommons.org/licenses/by-nc/3.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Editorial
Yip, Terry Cheuk-Fung
Wong, Grace Lai-Hung
Wong, Vincent Wai-Sun
Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact
title Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact
title_full Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact
title_fullStr Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact
title_full_unstemmed Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact
title_short Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact
title_sort negligible risk of hepatocellular carcinoma in chronic hepatitis b patients in immune-tolerant phase: myth or fact
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046624/
https://www.ncbi.nlm.nih.gov/pubmed/33517606
http://dx.doi.org/10.3350/cmh.2021.0019
work_keys_str_mv AT yipterrycheukfung negligibleriskofhepatocellularcarcinomainchronichepatitisbpatientsinimmunetolerantphasemythorfact
AT wonggracelaihung negligibleriskofhepatocellularcarcinomainchronichepatitisbpatientsinimmunetolerantphasemythorfact
AT wongvincentwaisun negligibleriskofhepatocellularcarcinomainchronichepatitisbpatientsinimmunetolerantphasemythorfact